Exploring Racial Differences in Patient Centeredness of Care (PCC) During Breast Cancer (BC) Chemotherapy Clinical Visits

Robertson-Jones, Tinnikkar Angel; Tissue, Madison M.; Connolly, Mary; Gallups, Sarah; Bender, Catherine M.; Rosenzweig, Margaret

doi:10.1007/s40615-018-0503-0

Cited by 7 publications

(9 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, we did find that clinician underestimation of certain symptoms was greater in nonwhite patients than white patients. This finding warrants further research but also reflects the larger literature documenting racial disparities in patient‐provider communication 30‐33 as well as racial differences in symptom management experiences 34 …”

Section: Discussionsupporting

confidence: 56%

Congruence of patient‐ and clinician‐reported toxicity in women receiving chemotherapy for early breast cancer

Nyrop

Deal

Reeve

et al. 2020

Cancer

View full text Add to dashboard Cite

Background The National Cancer Institute's Patient‐Reported Outcomes Version of the Common Terminology Criteria for Adverse Events, collected alongside the clinician‐reported Common Terminology Criteria for Adverse Events, enables comparisons of patient and clinician reports on treatment toxicity. Methods In a multisite study of women receiving chemotherapy for early‐stage breast cancer, symptom reports were collected on the same day from patients and their clinicians for 17 symptoms; their data were not shared with each other. The proportions of moderate, severe, or very severe patient‐reported symptom severity were compared with the proportions of clinician‐rated grade 2, 3, or 4 toxicity. Patient‐clinician agreement was assessed via κ statistics. Chi‐square tests investigated whether patient characteristics were associated with patient‐clinician agreement. Results Among 267 women, the median age was 58 years (range, 24‐83 years), and 26% were nonwhite. There was moderate scoring agreement (κ = 0.413‐0.570) for 53% of symptoms, fair agreement for 41% (κ = 0.220‐0.378), and slight agreement for 6% (κ = 0.188). For example, patient‐reported and clinician‐rated percentages were 22% and 8% for severe or very severe fatigue, 41% and 46% for moderate fatigue, 32% and 39% for mild fatigue, and 6% and 7% for none. Clinician severity scores were lower for nonwhite patients in comparison with white patients for peripheral neuropathy, nausea, arthralgia, and dyspnea. Conclusions Although clinician reporting of symptoms is common practice in oncology, there is suboptimal agreement with the gold standard of patient self‐reporting. These data provide further evidence supporting the integration of patient‐reported outcomes into oncological clinical research and clinical practice to improve monitoring of symptoms as well as timely interventions for symptoms.

show abstract

Section: Discussionsupporting

confidence: 56%

Congruence of patient‐ and clinician‐reported toxicity in women receiving chemotherapy for early breast cancer

Nyrop

Deal

Reeve

et al. 2020

Cancer

View full text Add to dashboard Cite

show abstract

“…Although all these studies were aimed at developing ‘PCC for breast cancer patients’, the answer to the question what PCC essentially means, was not obvious in most of the texts. In 2 out of 60 included publications, PCC was explicitly defined: (a) “Patient‐centeredness reflects a commitment to work for and with patients, to make the system easy for patients to get what they need” 24,25 and (b) “ Care that is respectful of and responsive to individual patient preferences, needs and values and that ensures that patient values guide all clinical decisions” 26,27 . In 43 out of the other 58 publications that were analysed, one or more implicit meanings of “PCC for breast cancer patients” could be extracted.…”

Section: Resultsmentioning

confidence: 99%

“…47 Other studies concentrate on patient values. In those cases the unravelling of the individual or sociocultural context was aimed at by either the use of questionnaires † † † † † † ,, 48 organizational changes ‡ ‡ ‡ ‡ ‡ ‡ ,,25 a cultural change § § § § § § ,, 49 targeted training of the healthcare provider ¶ ¶ ¶ ¶ ¶ ¶ , 28 or, more generally, by a plea for more commitment of the healthcare provider******* ,. 50 Finally, patients themselves can be taught to take charge in drawing the health provider's attention to their values † † † † † † † ,.…”

Section: B O X 1 Extraction Fieldsmentioning

confidence: 99%

“…Justice here means the reduction of health disparities either by eliminating the difference between healthcare institutes † † † † , 38 or by defending the rights of vulnerable groups: patients from lower social-economic classes ‡ ‡ ‡ ‡ , 42 , low literacy patients § § § § , 43 and patients from ethnic minorities ¶ ¶ ¶ ¶ ,. 28 In 13 articles, an answer to the "Why? "-question could not be found.…”

Section: B O X 1 Extraction Fieldsmentioning

confidence: 99%

“…For example one variable application is "from the patients' perspective" † ,. 28 In some articles interpreting PCC as such, patients' needs were accentuated ‡ ,. 29 In other articles of this group, patients' values were predominantly at stake § ,.…”

Section: Content Analysismentioning

confidence: 99%

See 2 more Smart Citations

Diversity of interpretations of the concept “patient‐centered care for breast cancer patients”; a scoping review of current literature

Pel

Engelberts

Schermer

2021

Evaluation Clinical Practice

View full text Add to dashboard Cite

Rationale, aims and objectives: Patient-centered care is considered a vital component of good quality care for breast cancer patients. Nevertheless, the implementation of this valuable concept in clinical practice appears to be difficult. The goal of this study is to bridge the gap between theoretical elaboration of "patient-centered care" and clinical practice. To that purpose, a scoping analysis was performed of the application of the term "patient-centered care in breast cancer treatment" in present-day literature.Method: For data-extraction, a literature search was performed extracting references that were published in 2018 and included the terms "patient-centered care" and "breast cancer". The articles were systematically traced for answers to the following three questions: "What is patient-centered care?", "Why perform patient-centered care?", and "How to realize patient-centered care?". For the content analysis, these answers were coded and assembled into meaningful clusters until separate themes arose which concur with various interpretations of the term "patient-centered care".Results: A total of 60 publications were retained for analysis. Traced answers to the three questions "what", "why", and "how" varied considerably in recent literature concerning breast cancer treatment. Despite the inconsistent use of the term "patient-centered care," we did not find any critical consideration about the nature of the concept, regardless of the applied interpretation. Interventions that are supposed to contribute to the heterogeneous concept of patient-centered care as such, seem to be judged desirable, virtually without empirical justification. Conclusions:We propose, contrary to previous efforts to define "patient-centered care" more accurately, to embrace the heterogeneity of the concept and apply "patientcentered care" as an umbrella-term for all healthcare that intends to contribute to the acknowledgement of the person in the patient. For the justification of measures to realize patient-centered care for breast cancer patients, instead of a mere contribution to the abstract concept, we insist on the demonstration of desirable real-world effects.

show abstract

Redefining Doctor-Patient Relationship and Professional Ethics in Elderly Care

Kaur¹,

Lum

2022

Quality of Life in Asia

View full text Add to dashboard Cite

Exploring Racial Differences in Patient Centeredness of Care (PCC) During Breast Cancer (BC) Chemotherapy Clinical Visits

Cited by 7 publications

References 25 publications

Congruence of patient‐ and clinician‐reported toxicity in women receiving chemotherapy for early breast cancer

Congruence of patient‐ and clinician‐reported toxicity in women receiving chemotherapy for early breast cancer

Diversity of interpretations of the concept “patient‐centered care for breast cancer patients”; a scoping review of current literature

Redefining Doctor-Patient Relationship and Professional Ethics in Elderly Care

Contact Info

Product

Resources

About